No Data
No Data
Mesoblast To Issue 10.2 Million Shares to Osiris Therapeutics Following US FDA Approval of Cell Treatment; Shares Fall 6%
Mesoblast Limited Announces Proposed Securities Issue
State Street Corporation Ceases Substantial Holding in Mesoblast
Trending Stocks Today | Treasure Global Surges 74.03% Post-Market
Mesoblast Stock Rockets to New 52-Week High
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
星國榮少 : Short term target should go to 30 first